Stress-activated mitogen-activated protein kinases c-Jun NH 2-terminal kinase and p38 target Cdc25B for degradation

Cancer Research

Volumn 69, Issue 16, 2009, Pages 6438-6444

  Uchida, Sanae ^a   Yoshioka, Katsuji ^a   Kizu, Ryoichi ^b   Nakagama, Hitoshi ^c   Matsunaga, Tsukasa ^a   Ishizaka, Yukihito ^d   Poon, Randy Y C ^e   Yamashita, Katsumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANISOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE PHOSPHATASE; SERINE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL STRESS; CELLULAR DISTRIBUTION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SITE DIRECTED MUTAGENESIS;

ANISOMYCIN; ANTINEOPLASTIC AGENTS; CATALYTIC DOMAIN; CDC25 PHOSPHATASES; CELL CYCLE; CELL NUCLEUS; DNA DAMAGE; HELA CELLS; HUMANS; HYDROXYUREA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MUTANT PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SYNTHESIS INHIBITORS; PROTEIN TRANSPORT;

EID: 69249131661     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0869     Document Type: Article

References (36)

1. 1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 2001;13:738-47.
2. Busino L, Chiesa M, Draetta GF, Donzelli M. Cdc25A phosphatase: combinatorial phosphorylation ubiquitylation and proteolysis. Oncogene 2004;23:2050-6.
3. 2/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J 2002;21:5911-20.
4. Lindqvist A, Källström H, Lundgren A, Barsoum E, Rosenthal CK. Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J Cell Biol 2005;171:35-45.
5. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003;3:421-9.
6. β-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev 2003;17:3062-74.
7. Chen MS, Hurov J, White LS, Woodford-Thomas T, Piwnica-Worms H. Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol Cell Biol 2001;21:3853-61.
8. Ferguson AM, White LS, Donovan PJ, Piwnica-Worms H. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol Cell Biol 2005;25:2853-60.
9. Lincoln AJ, Wickramasinghe D, Stein P, et al. Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation. Nat Genet 2002;30:446-9.
10. 2-M transition. J Cell Sci 2004;117:2523-31.
11. Kramer A, Mailand N, Lukas C, et al. Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nat Cell Biol 2004;6:884-91.
12. Schmitt E, Boutros R, Froment C, Monsarrat B, Ducommun B, Dozier C. CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage. J Cell Sci 2006;119:4269-75.
13. Uchida S, Kuma A, Ohtsubo M, et al. Binding of 14-3-3β but not 14-3-3σ controls the cytoplasmic localization of CDC25B: binding site preferences of 14-3-3 subtypes and the subcellular localization of CDC25B. J Cell Sci 2004;117:3011-20.
14. Boutros R, Dozier C, Ducommun B. The when and where of CDC25 phosphatases. Curr Opin Cell Biol 2006;18:185-91.
15. Forrest A, Gabrielli B. Cdc25B activity is regulated by 14-3-3. Oncogene 2001;20:4393-401.
16. Davezac N, Baldin V, Gabrielli B, et al. Regulation of CDC25B phosphatases subcellular localization. Oncogene 2000;19:2179-85.
17. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK JNK and p38 protein kinases. Science 2002;298:1911-2.
18. 2/M transition and S phase progression in response to UV irradiation. Mol Cell 2005; 17:37-48.
19. 2/M checkpoint symphony. Curr Opin Genet Dev 2002;12:92-7.
20. Goloudina A, Yamaguchi H, Chervyakova DB, Appella E, Fornace AJ, Jr., Bulavin DV. Regulation of human Cdc25A stability by serine 75 phosphorylation is not sufficient to activate an S phase checkpoint. Cell Cycle 2003;2:473-8.
21. Goss VL, Cross JV, Ma K, Qian Y, Mola PW, Templeton DJ. SAPK/JNK regulates cdc2/cyclin B kinase through phosphorylation and inhibition of cdc25C. Cell Signal 2003;15:709-18.
22. Lindqvist A, Källström H, Karlsson-Rosenthal C. Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress. J Cell Sci 2004;117:4979-90.
23. Uchida S, Ohtsubo M, Shimura M, et al. Nuclear export signal in CDC25B. Biochem Biophys Res Commun 2004;316:226-32.
24. Uchida S, Kubo A, Kizu R, et al. Amino acids C-terminal to the 14-3-3 binding motif in CDC25B affect the efficiency of 14-3-3 binding. J Biochem (Tokyo) 2006;139:761-9.
25. 2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001;411:102-7.
26. Lemaire M, Froment C, Boutros R, et al. CDC25B phosphorylation by p38 and MK-2. Cell Cycle 2006;5:1649-53.
27. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858-68.
28. Cano E, Hazzalin CA, Mahadevan LC. Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol Cell Biol 1994;14:7352-62.
29. Iordanov MS, Pribnow D, Magun JL, et al. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the a-sarcin/ricin loop in the 28S rRNA. Mol Cell Biol 1997;17:3373-81.
30. Kanemori Y, Uto K, Sagata N. β-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Proc Natl Acad Sci U S A 2005;102:6279-84.
31. Hutter D, Chen O, Barnes J, Liu Y. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochem J 2000;352:155-63.
32. Uto K, Inoue D, Shimuta K, Nakajo N, Sagata N. Chk1 but not Chk2 inhibits Cdc25 phosphatases by a novel common mechanism. EMBO J 2004;23:3386-96.
33. Kristjánsdóttir K, Rudolph J. Cdc25 phosphatases and cancer. Chem Biol 2004;11:1043-51.
34. Boutros R, Lobjois J, Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 2007;7:495-507.
35. Galaktionov K, Lee AK, Eckstein J, et al. CDC25 phosphatases as potential human oncogenes. Science 1995;269:1575-7.
36. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005;5:773-85.